|
HS Code |
142331 |
| Product Name | Coptidis Alkaloids |
| Main Component | Berberine |
| Source Plant | Coptis chinensis |
| Appearance | Yellow powder |
| Solubility | Soluble in water and ethanol |
| Molecular Formula | Varies by alkaloid, e.g., Berberine: C20H18NO4+ |
| Usage | Herbal supplement, pharmaceutical ingredient |
| Purity | Typically >98% |
| Extraction Method | Solvent extraction |
| Storage Conditions | Cool, dry place, away from light |
| Common Applications | Antibacterial, anti-inflammatory, metabolic regulation |
| Cas Number | 2086-83-1 (Berberine) |
| Country Of Origin | China |
As an accredited Coptidis Alkaloids factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Coptidis Alkaloids are packaged in a sealed amber glass bottle, 10g net weight, labeled with product details and safety information. |
| Shipping | Coptidis Alkaloids are shipped in tightly sealed containers, protected from light, moisture, and extreme temperatures. Packaging complies with international regulations for chemical transport, ensuring safety and product integrity. Material Safety Data Sheets are included, and shipping follows standards for non-hazardous plant-derived substances. Expedited options are available upon request. |
| Storage | Coptidis Alkaloids should be stored in a tightly sealed container, protected from light and moisture, at room temperature (15–25°C). Keep away from incompatible substances and sources of ignition. Store in a dry, well-ventilated place. Proper storage ensures stability and prevents degradation or contamination, preserving the compound's efficacy for research or pharmaceutical use. |
| Purity 98%: Coptidis Alkaloids with purity 98% is used in pharmaceutical formulation development, where enhanced antimicrobial efficacy is achieved. Molecular Weight 336.4 g/mol: Coptidis Alkaloids with molecular weight 336.4 g/mol is used in anti-inflammatory drug research, where molecular consistency ensures reproducible inhibition of pro-inflammatory markers. Particle Size <10 μm: Coptidis Alkaloids with particle size less than 10 micrometers are used in nanoparticle drug delivery systems, where improved cellular uptake and bioavailability are observed. Stability Temperature 25°C: Coptidis Alkaloids with stability temperature of 25°C are used in herbal extract preservation, where shelf life and potency retention are maintained. Viscosity Grade Low: Coptidis Alkaloids of low viscosity grade are used in oral suspension formulations, where uniform dispersion and ease of administration are ensured. Water Solubility 120 mg/L: Coptidis Alkaloids with water solubility of 120 mg/L are used in intravenous infusion preparation, where rapid dissolution and consistent plasma levels are facilitated. Melting Point 145°C: Coptidis Alkaloids with melting point 145°C are used in solid dosage tablet manufacturing, where thermal stability during processing is guaranteed. UV Absorption λmax 350 nm: Coptidis Alkaloids exhibiting UV absorption at λmax 350 nm are used in quality control protocols, where precise quantification and batch consistency are achieved. |
Competitive Coptidis Alkaloids prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Anyone in this industry recognizes Coptidis Alkaloids as a staple for pharmaceutical and botanical applications. But too often, talk about this raw material circles around numbers or hard-to-picture properties. Years of producing and refining this extract in our facility have given us firsthand insight into what sets Coptidis Alkaloids apart, the value its unique makeup brings, and where users can run into both promise and pain points. Making this product daily—tracking each batch through every step—gives a different view than one pulled from catalog or transit docs.
Coptidis Alkaloids aren’t simply plucked from any source. We have learned over time that the quality of Coptis chinensis roots matters, down to origin, age, and handling. Harvests delivered after heavier seasonal rains can carry more moisture, so our prepping crew adjusts drying and extraction cycles as needed. Consistency matters in later steps, and minor variations upstream can have measurable impact—berberine, palmatine, coptisine, and jatrorrhizine content will show.
During extraction, precise pH calibration and temperature control are non-negotiable if we want clean, concentrated alkaloid output. Any lapse in solvent handling or temperature monitoring leads to off-notes—sometimes bitter, sometimes muddy. Our facilities have moved toward semi-automated monitoring not to chase technology for bragging rights, but because repeat customers count on batch-to-batch reliability. These subtle controls cannot be skipped, especially with the global market quick to notice performance dips.
Our team currently produces a standardized Coptidis Alkaloids extract designated under our "CA-80" model. This material consistently delivers total alkaloid content over 80%, verified by HPLC. We have stuck with this benchmark after feedback from major customers: less variability in downstream tablet and capsule applications, stronger yield on their QC.
In powder form, the CA-80 presents a yellow to yellow-brown color. The feel under the glove is fine and dry, but not dusty—achieved by tight moisture control and sieving after the final drying stage. Handling and packaging follow GMP standards, with all packaging performed in stainless environments to avoid contamination. We've resisted chasing ultra-high concentrations because our experience shows past 85%, you start seeing processing inefficiencies and increased bitterness, which can swallow up gains for most users.
Over the years, clients from pharmaceutical, nutraceutical, and research sectors land on coptidis extracts for one central reason: the alkaloids themselves, especially berberine. Why not just isolate berberine? Some try, but the synergy among the mix of alkaloids in whole extract gives better biological activity in many formulas, as seen in clinical feedback and papers published worldwide.
End users turn to our product for tablet, capsule, granule, and even beverage base manufacturing. Traditional herbal research groups chase the multi-alkaloid matrix because it better mimics ancient preparations and delivers not just antibacterial performance, but broad spectrum anti-inflammatory and metabolic action. Pharmaceuticals drill down into berberine for glucose and lipid modulation studies. In both fields, users routinely cite purity and content unevenness as bottlenecks if sourcing lower-standard material.
Some direct competition provides fractionated alkaloids, or focuses solely on berberine hydrochloride, purified to above 97%. These single-compound offerings have a place, but strip away the supporting cast many researchers value. There’s a tradeoff: super-high purity isolates carry reduced complexity, which can reduce risk in drug trials but sideline the potential for broader botanical efficacy seen with a natural spectrum extract.
Earlier in our company’s life, batches sometimes drifted outside tolerance windows. That meant calls from clients, unexpected off-spec returns, and those cases always forced hard looks at raw material batches and every extraction step. Standard HPLC and TLC methods for quantifying berberine, palmatine, and coptisine content are only as good as sample prep. Over the years, we built in more frequent spot checks—our lab pulls sub-samples before final blending, not simply after.
More important, our feedback loop grew: finished product complaints almost always pointed to changes in upstream farm practices, age of root, or supplier deviation when pressed for details. We now lock in suppliers through rolling audit contracts and have plant techs on site for major harvests, sampling before bales are even sent to our factory. This process took years, but our clients talk about visible improvements in color, stability, and consistency since we made these changes.
Ask around, and anyone can make claims about “highest alkaloid purity” or “pharmaceutical grade.” Time with the raw product shows that not all alkaloid extracts handle the same, especially once blended into formulas where moisture, particle size, or slight solvent residue cause separation or coating issues. More than a few times, R&D partners brought us competitor samples that failed compression testing or showed visible clumping under accelerated stability trials. We learned that pressing for over-concentration gives diminishing returns—material turns sticky, harder to blend, and less forgiving in long-term storage, particularly in humid climates.
Our own process always prioritizes balance over gross numbers. While competitors might tout extracts boasting 90% or higher, most end-users don’t see added benefits but come back to us for consistent blending, even flow during high-speed tableting, and predictable results in dissolution rates. For beverage or nutritional blends, over-pure material can actually increase bitterness, pushing flavor chemists to mask with more additives. We stick with 80–85% because it’s the sweet spot—bioactivity remains high, processability stays manageable, and feedback from on-the-ground formulators overwhelmingly supports this range.
Counterfeit and adulterated material remains a pervasive risk. Some suppliers spike extracts with synthetic berberine or yellow dyes. Most detection methods catch these tricks, but end-users shoulder the fallout if it slips past. Our extraction chain includes in-house and third-party verification to keep cheats out. Years of field experience taught us not to compromise on this, and clients have stuck with us after watching others pay the price of costly recalls and regulatory headaches.
Much of our business has stayed with us because of how we handle customization and support—not just because of test-sheet numbers. Some customers want alkaloid content tuned slightly higher or lower. Because we run everything on-site with full traceability, responding to these requests doesn’t mean shipping off the job to another facility or guessing batch performance.
With pharmaceutical partners, we keep production windows tight, schedule deliveries to match their GMP windows, and run duplicate samples through our and their own QC arms for confirmation. For nutraceutical clients, who often face global regulatory shifts, full COA sets and country-of-destination compliance are built into every shipment. We maintain clear communication—one lesson learned is that even minor informal process changes need to be flagged early, because pilot-scale customers especially build on routine. Anything less breaks trust; too many formula recalls in the field are traceable to process drift at the raw material stage.
Some researchers and boutique supplement firms stay obsessed with minor alkaloids below 1%—for these, we can tailor isolation methods or provide extended run reports. We always stress that the main performance comes from the primary four alkaloids, but our flexibility allows for further fractionation if backed by clear analytical targets.
Our process starts with wildharvested or cultivated Coptis chinensis, aged three or more years for impactful alkaloid buildup. Washing, slicing, and monitored air-drying prepare the roots without high-heat interventions that break down natural phenolics. Extraction runs on ethanol, which, after years of evaluating various solvents, remains effective at pulling full-spectrum alkaloids without excessive tannin bleed.
The extracted liquid undergoes stepwise filtration. Fine-tuning pH lowers the risk of secondary precipitate, based on repeated real-world headaches experienced during scale-up. Solvent recovery gets priority since pharmaceutical clients push us to keep trace solvents below international thresholds—directly measurable in every batch. Final drying uses vacuum ovens, not open ambient drying, which avoids hydrolysis and preserves the complex yellow coloration customers expect.
Many years ago, we used to ship in fiber drums with standard liners. After client feedback about moisture ingress and color fading, we switched entirely to food-grade polyethylene drum linings in double-layer format. One poor batch cost us a long-term customer—a lesson that changed how we handle every shipment, even if it increased costs and slowed early output.
Market demand for Coptidis Alkaloids has grown, but quality controls have not always kept pace. Smaller operations sometimes cut corners to raise yields, overlooking the cumulative impact of solvent residues or incomplete purification. Global demand pressures smaller harvesters to ship less mature root, impacting every downstream process. We engage directly with growers, reserve crops two years in advance, and train supplier partners to meet elevated standards. These extra steps translate into steadier supply and fewer last-minute shortages during peak demand cycles, especially when national herbal medicine seasons shift.
Counterfeit risk remains real. We see more “discount” offers made to buyers, but almost always these come with lower or non-standard alkaloid ratios, higher microbial counts, or inconsistent batch logs. One regulatory recall can undo years of market work for end-user brands. Our clients reiterate the value of verified traceability; a lesson driven home by stories in the news and from our own experience seeing unverified shipments seized at international checkpoints.
There’s increased discussion about novel delivery formats—fast-dissolving films, functional beverages, and targeted-release capsules—where processability and particle size distribution play an outsized role. We've worked alongside formulation scientists to adjust our milling and drying protocols to support these needs, providing modified particle size ranges or extra QA reports on request. We also maintain a direct feedback pipeline so repeated roadblocks in pilot runs come to us in real time, not buried in quarterly reports.
Much gets said about “sustainable sourcing” and “traceability” in botanical extraction, but on the ground, meeting these standards requires up-front investment and hands-on management. We trace each batch back to the plot and harvest date. Most buyers say traceability matters, but only a handful follow up. For us, full field-to-factory logs head off future regulatory headaches and let us address root issues—literally—when alkaloid content falls short. Our audit system caught one instance of supplier fraud two years ago, preventing a costly recall for a pharmaceutical client down the line.
We’re committed to supporting both wild and cultivated sources, aiming for balance between sustained yield and pharmacopoeial quality. Not every root makes the cut. About 25% of wildharvest output is set aside after intake testing, repurposed for non-pharmaceutical uses rather than risking batch contamination or subpar results. On the farm side, we work with growers using integrated pest management and minimal artificial fertilizer, again confirmed by third-party soil and tissue testing.
This attention may seem like overkill, but our history shows that cutting corners early means headaches later. Only consistent, honest engagement with our upstream partners lets us meet ongoing client needs for transparency and quality.
We've seen the pitfalls of letting sales outrun lab work. With every large order, we share microbatch samples for process confirmation, encourage open discussion of test results, and schedule production to closely mirror pilot timelines. These close technical partnerships break down the silo between supplier and client, making mid-cycle changes easier to flag and adjust.
Every year, we run in-house capability audits, benchmarking our Coptidis Alkaloids CA-80 against international standards. Internal and third-party analyses consistently match or beat pharmacopoeia minimums for total alkaloid and heavy metals. We publish both types of data openly on request, aiming to keep our practices in plain view. Clients face shifting requirements across different markets, and open access to analysis removes guesswork and reduces paperwork with both health authorities and insurance underwriters.
We know the learning never stops. Regulatory rules shift, climate influences crop cycle, and downstream users try new formats that stress old process limits. We listen, adapt, and hold ourselves to the benchmarks set by those who blend, table, and dose our extracts where they matter—in real products, not test tubes.
Supplying Coptidis Alkaloids is more than shipping yellow powder. Every batch tells a story about the field, the process, and the final application. Our approach stays rooted in the needs of customers who use our extract to develop real products for the health and research fields. We have weathered the ups and downs of the supply chain, the push and pull of purity versus processability, and the ever-present demand for honest, traceable material.
We hold firm that the only acceptable approach is one guided by experience. We won’t sacrifice consistency for temporary gains in concentration or short-term sales spikes. We stay hands-on with our process and supply chain, because reliability and transparency aren't slogans—they’re the foundation of every successful client partnership we've built.
Our focus remains clear: provide a truly consistent, high-quality Coptidis Alkaloids extract that supports both innovation and tradition, makes life easier for formulators and manufacturers, and upholds the standards required for safe, effective products worldwide.